LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 15 of 15: Calculated dose-response metrics. - Dataset (ID:20252)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | GR_AOC |
|---|---|---|
| MCF 10A | BI-2536 | 1.0248 |
| MCF 10A | SNS-032 | 1.0761 |
| MCF 10A | BMS345541 | 0.0397 |
| MCF 10A | Brivanib | 0.1592 |
| MCF 10A | Buparlisib | 0.4482 |
| MCF 10A | BX-912 | 0.5056 |
| MCF 10A | Alpelisib | 0.1674 |
| MCF 10A | Canertinib | 0.7356 |
| MCF 10A | Celastrol | 0.4960 |
| MCF 10A | CGP60474 | 1.1707 |
| MCF 10A | CHIR-99021 | 0.0528 |
| MCF 10A | CP466722 | 0.0269 |
| MCF 10A | CP724714 | 0.0142 |
| MCF 10A | Crizotinib | 0.1680 |
| MCF 10A | Momelotinib | 0.2434 |
| MCF 10A | Dasatinib | 0.8024 |
| MCF 10A | Dovitinib | 0.4978 |
| MCF 10A | Enzastaurin | -0.0030 |
| MCF 10A | Erlotinib | 0.5827 |
| MCF 10A | Alvocidib | 1.2235 |
| MCF 10A | Foretinib | 0.4073 |
| MCF 10A | Pictilisib | 0.4699 |
| MCF 10A | GDC-0980 | 0.7043 |
| MCF 10A | Gefitinib | 0.6817 |
| MCF 10A | Geldanamycin | 1.0555 |